Concerning ‘Hepatitis C Virus’ (Transfus Med Hemother2003;30:239–250)

Publisher： Karger

E-ISSN： 1660-3818|30|6|288-

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.30, Iss.6, 2003-12, pp. : 288-

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Concerning Hänecke P, Klouche M: ThrombelastographyToday: Practicability and Analytical Power. Transfus Med Hemother 2007;34:421–428

By  

Transfusion Medicine and Hemotherapy, Vol. 35, Iss. 4, 2008-07 ,pp. : 324-326

Karger

Access to resources Recommend Favorite

Concerning Chapter 5 – Human Albumin; in Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives, 4th ed. Transfus Med Hemother 2009;36(6):399–407

By  

Transfusion Medicine and Hemotherapy, Vol. 37, Iss. 2, 2010-03 ,pp. : 98-99

Karger

Access to resources Recommend Favorite

Concerning Caspari et al: Pathogen Inactivation of Cellular Blood Products – More Security for the Patient or Less? Transfus Med Hemother 2003;30:261–263

By  

Transfusion Medicine and Hemotherapy, Vol. 32, Iss. 1, 2005-01 ,pp. : 45-48

Karger

Access to resources Recommend Favorite

Erwiderung zum Kommentar von Dr. Sascha Rolf Lüder: Transfus Med Hemother 2011;38(6): DOI: 10.1159/000334844

By  

Transfusion Medicine and Hemotherapy, Vol. 38, Iss. 6, 2011-11 ,pp. : 396-396

Karger

Access to resources Recommend Favorite

Concerning: Zeiler et al: In vitro properties of platelet concentrates. Infus Ther Transfus Med 2001;28:9–14.

By  

Transfusion Medicine and Hemotherapy, Vol. 28, Iss. 4, 2001-08 ,pp. : 222-222

Karger

Access to resources Recommend Favorite